DIFFERENTIAL RNA EXPRESSION OF THE PS2 GENE IN THE HUMAN BENIGN AND MALIGNANT PROSTATIC TISSUE
Abstract
Purpose:
The pS2 trefoil protein has been detected in close association with neuro-endocrine differentiation in prostate cancer and prostatic intraepithelial neoplasia. These preliminary results have suggested that pS2 is a candidate as a specific marker for prostate cancer tissue. To ascertain the specificity of pS2 in prostate cancer tissue, we have used an RT-PCR method from prostate biopsies provided from human malignant and benign prostatic hyperplasia (BPH) tissue.
Materials and Methods:
Prostate biopsies were obtained from transrectal biopsies from 153 patients with an abnormal DRE or a PSA more than 4 ng./ml. or symptoms of BPH and a PSA more than 4 ng./ml. Total RNA was extracted from fresh frozen specimens of tissue samples. Detection of pS2 transcript compared with GADPH transcripts was done using RT-PCR.
Results:
Biopsy results showed that 108 patients had prostate cancer (average Gleason score 6.39 +/− 0.74) and 45 patients had BPH. PS2 RT-PCR results showed that PS2 RNA expression was negative in 83% of the BPH cases. Conversely, 92% of prostate cancer specimens were positive (Chi-square: 86.09, p <0.001). There was no correlation with tumor stage or the Gleason score. Comparing the expression of pS2 in BPH and localized prostate cancer, we found a sensitivity of 92% and a specificity of 82%.
Conclusions:
On this large sample of prostate biopsies from patients at risk of having prostate cancer, pS2 was demonstrated as an interesting marker significantly associated with prostate cancer. Further work on the expression of pS2 according to differentiation and hormonal status is in progress.
References
- 1 : A retrospective and prospective overview of prostate-specific antigen. J. Cancer Res. Clin. Oncol.1997; 123: 583. Google Scholar
- 2 : The molecular pathology of urological malignancies. J. Pathol.1997; 183: 380. Google Scholar
- 3 : Molecular markers for prostate cancer metastasis. Developing diagnostic methods for predicting the aggressiveness of prostate cancer. Am. J. Pathol.1997; 150: 1511. Google Scholar
- 4 : Prostatic cancer: future prospects for diagnosis and screening. Br. J. Urol.1997; 79: 107. Google Scholar
- 5 : Sequence of the pS2 mRNA induced by estrogen in the human breast cancer cell line MCF-7. Nucleic Acids Res.1984; 12: 2861. Google Scholar
- 6 : Structure of the human oestrogen-responsive gene pS2. Nucleic Acids Res.1987; 15: 1401. Google Scholar
- 7 : Prediction of relapse and survival in breast cancer patients by pS2 protein status. Cancer Res.1990; 50: 3832. Google Scholar
- 8 : Expression of the oestrogen regulated pNR-2 mRNA in human breast cancer: relation to oestrogen receptor mRNA levels and response to tamoxifen therapy. Br. J. Cancer1990; 61: 32. Google Scholar
- 9 : pNR-2/pS2 immunohistochemical staining in breast cancer: correlation with prognostic factors and endocrine response. Br. J. Cancer1991; 63: 615. Google Scholar
- 10 : Gastric mucosa abnormalities and tumorigenesis in mice lacking the pS2 trefoil protein [see comments]. Science1996; 274: 259. Google Scholar
- 11 : An immunohistochemical survey of pS2 expression in human epithelial cancers. Int. J. Cancer1992; 50: 302. Google Scholar
- 12 : Expression of the pS2 gene in normal, benign and neoplastic human stomach. Int. J. Cancer1989; 44: 806. Google Scholar
- 13 : Detection of pS2 messenger RNA in gynecological cancers. Cancer Res.1990; 50: 1800. Google Scholar
- 14 : Differential expression of the pS2 protein in the human prostate and prostate cancer: association with premalignant changes and neuroendocrine differentiation. Hum. Pathol.1995; 26: 824. Google Scholar
- 15 : Prediction of prognosis for prostatic adenocarcinoma by combined histological grading and clinical staging. J. Urol.1974; 111: 58. Abstract, Google Scholar
- 16 : Single-step method of RNA isolation by acid guanidinium thiocyanate- phenol-chloroform extraction. Anal. Biochem.1987; 162: 156. Google Scholar
- 17 : Sensitive detection of estrogen receptor RNA by polymerase chain reaction assay [see comments]. JNCI1990; 82: 858. Google Scholar
- 18 : Expression of pN-2/pS2 protein in diverse human epithelial tumours. Br. J. Cancer1991; 64: 677. Google Scholar
- 19 : Expression of pS2 protein and estrogen and progesterone receptor status in breast cancer. Acta Cytol.1997; 41: 713. Google Scholar
- 20 : DNA ploidy and pS2 protein expression in breast cancer. Cytopathology1997; 8: 171. Google Scholar
- 21 : Trefoil proteins: their role in normal and malignant cells. J. Pathol.1997; 183: 4. Google Scholar
- 22 : Expression of pS2-, c-erbB-2, and cathepsin D during the menstrual cycle in human breast cancers. Ann. Surg. Oncol.1997; 4: 462. Google Scholar
- 23 : Ligand-independent activation of steroid hormone receptors. J. Mol. Med.1998; 76: 469. Google Scholar
- 24 : Prostate-specific antigen production in the female breast: association with progesterone. Cancer Epidemiol. Biomarkers Prev.1998; 7: 315. Google Scholar
- 25 : The 5' flanking region of the pS2 gene contains a complex enhancer region responsive to oestrogens, epidermal growth factor, a tumour promoter (TPA), the c-Ha-ras oncoprotein and the c-jun protein. EMBO J.1989; 8: 823. Google Scholar
- 26 : Induction of pS2 and hSP genes as markers of mucosal ulceration of the digestive tract. Gastroenterol.1991; 100: 375. Google Scholar
- 27 : Expression of an estrogen-induced breast cancer-associated protein (pS2) in benign and malignant human ovarian cysts. Lab. Invest.1994; 71: 188. Google Scholar
- 28 : pS2 and PAI-1 in ovarian cancer: correlation to pathohistological parameters. Anticancer Res.1997; 17: 679. Google Scholar
From the Service d'Urologie et de la Chirurgie de la Transplantation et le Departement d'Anatomo Pathologie, Hopital Edouard HERRIOT, the Laboratoire de Genetique, Universite Claude Bernard Lyon, Faculte de Medecine, the Institut de Genetique et de Biologie Moleculaire et Cellulaire, CNRS/INSERM/ULP, Illkirch and the Laboratoire des radio isotopes, Hopital Edouard HERRIOT, Lyon, France
(Colombel) Requests for reprints: Service d'Urologie et de la Chirurgie de la Transplantation, Hopital Edouard HERRIOT, 5 place d'Arsonval, 69437 LYON Cedex 03, France.
Supported by a grant from “la Ligue du Rhone.”
